DBD Earnings

DBD reported its earnings on 2026-04-30, showcasing a revenue of 891.80M against an estimate of 865.20M, resulting in a 3.07% surprise. The EPS was 0.6, surpassing the expected 0.61 by -1.64%. The stock experienced a -7.41% price change on the earnings day and a -6.55% change over the next five days, reflecting market reactions to the results.

Following DBD's earnings announcement on 2026-04-30, the stock price moved by -7.41% on the day of the release. Over the subsequent five days, it saw a -6.55% change. Historically, DBD's stock price tends to shift by an average of -3.13% in the 10 days leading up to earnings and 2.3% in the 10 days following, providing insight into potential market.

For 2026/Q2, analysts estimate DBD's annual revenue to reach 926.90M, while the EPS is projected at 1.07. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between DBD's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, DBD's stock price typically moves by -3.13% in the 10 days before its earnings and 2.3% in the 10 days after. For the upcoming 2026/Q2 earnings, analysts expect an EPS of 1.07 and revenue of 926.90M.

The company reported a 5% increase in revenue and a 2 percentage point improvement in operating margin, indicating strong financial performance. Free cash flow also saw a significant 20% increase. Despite the lack of discussion on strategic initiatives and risk, the positive financial metrics and improved operational efficiency suggest a positive outlook, especially given the company's market cap, which suggests potential for stock price movement within the 2% to 8% range.